Abstract:BackgroundSystemic immune activation (inflammation) and immunosenescence develop in some people with advancing age. This process, known as “inflamm-aging,” is associated with physical frailty and sarcopenia. Meanwhile, successful antiretroviral therapy has led to a growing number of older HIV-1-infected individuals who face both age-related and HIV-1-related inflammation, which may synergistically promote physical decline, including frailty and sarcopenia. The purpose of our study was to determine if inflammation during treated HIV-1 infection worsens physical impairment in older individuals.MethodsWe determined the severity of HIV-associated inflammation and physical performance (strength and endurance) in 21 older HIV-infected individuals (54–69 years) receiving suppressive antiretroviral therapy, balanced for confounding variables including age, anthropometrics, and co-morbidities with 10 uninfected control individuals. Biomarkers for microbial translocation (lipopolysaccharide [LPS]), inflammation (soluble CD14 [sCD14], osteopontin, C-reactive protein [CRP], interleukin-6 [IL-6], soluble ICAM-1 [sICAM-1] and soluble VCAM-1 [sVCAM-1]), and coagulopathy (D-dimer) were assayed in plasma. Activation phenotypes of CD4+T cells, CD8+ T cells and monocytes were measured by flow cytometry. Physical performance was measured by 400 m walking speed, a short physical performance battery [SPPB], and lower extremity muscle strength and fatigue.ResultsOverall physical function was similar in the uninfected and HIV-infected groups. Compared to uninfected individuals, the HIV-infected group had elevated levels of sCD14 (P < 0.001), CRP (P < 0.001) and IL-6 (P = 0.003) and an increased frequency of CD4+ and CD8+ T cells with an immunosenescent CD57+ phenotype (P = 0.004 and P = 0.043, respectively). Neither plasma inflammatory biomarkers nor CD57+ T cells correlated with CD4+ T cell counts. Furthermore, none of the elevated inflammatory biomarkers in the HIV-infected subjects were associated with any of the physical performance results.ConclusionsWhen age-related co-morbidities were carefully balanced between the uninfected and HIV-infected groups, no evidence of inflammation-associated physical impairment was detected. Despite careful balancing for age, BMI, medications and co-morbidities, the HIV-infected group still displayed evidence of significant chronic inflammation, including elevated sCD14, CRP, IL-6 and CD57+ T cells, although the magnitude of this inflammation was unrelated to physical impairment.

Inflammation and reactivation of latent herpesviruses in older adults

The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection

Latent gammaherpesvirus exacerbates arthritis through modification of age-associated B cells

Anti-cytomegalovirus antibody levels stratify human immune profiles across the lifespan

The Dynamics of Herpesvirus and Polyomavirus Reactivation and Shedding in Healthy Adults: a 14-Month Longitudinal Study.

Herpes simplex virus 2 serology is associated with thinner whole-brain cortex in community-dwelling older adults

Antibody signatures against viruses and microbiome reflect past and chronic exposures and associate with aging and inflammation

Different CMV-specific effector T cell subtypes are associated with age, CMV serostatus, and increased systolic blood pressure

Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis

Chronic Low-grade Inflammation in the Elderly

Immune Biomarkers Predictive of Respiratory Viral Infection in Elderly Nursing Home Residents

Persistent infection with neurotropic herpes viruses and cognitive impairment

Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly

Reactivation of Human Herpesvirus 6 and Epstein-Barr Virus in relapsing remitting multiple sclerosis: association with disabilities, disease progression, and inflammatory processes.

CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age

Recruitment of inflammatory monocytes by senescent fibroblasts inhibits antigen-specific tissue immunity during human aging

Chronic and Latent Viral Infections and Leukocyte Telomere Length across the Lifespan of Female and Male Individuals Living with or without HIV

Herpesvirus Antibody Response and Occurrence of Symptoms in Acute and Post-Acute COVID-19 Disease

Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects

Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk

Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging